WeightControl.com: What are the main findings?
Response: The participants of this study had a 100% technical success rate with no major adverse events. The procedure resulted in a decrease in the mean BMI of the participants from initially being 43.6 to 41.2 one-year post-procedure.
WeightControl.com: What should readers take away from your report?
Response: This study demonstrates that BAE is a highly efficient and safe method for individuals who are severely obese compared to other embolic agents. BAE can allow participants to lose weight while also maintaining a well-balanced muscle-to-fat ratio.
WeightControl.com: What recommendations do you have for future research as a result of this work?
Response: Continuing research in weight loss and weight management in those who are severely obese is vital to assuaging the obesity epidemic in the United States. Our study will next look at longer-term results (18-24 months). Additionally, diversifying the sample and enlarging the sample size to allow the results to fit a greater range of participants would be necessary to create generalizable recommendations. However, this initial study demonstrates promising results.
WeightControl.com: Is there anything else you would like to add?
Response: BAE is an effective method for reducing weight while maintaining a healthy muscle-to-fat composition. It is a highly effective method that is feasible to perform. This study was funded by Boston Scientific, Siemens MRI, Siemens AT, and through NIH grants.
Disclosures: This study was funded by Boston Scientific, Siemens MRI, Siemens AT, and through NIH grants.
Citation: SIR 2024 abstract:
Bariatric Embolization of ArTeries with imaging visibLe EmbolicS (BEATLES): Pilot Study
https://www.jvir.org/article/S1051-0443(23)01155-7/fulltext
The information on WeightControl.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.
Last Updated on April 2, 2024 by weightcontrol